...
首页> 外文期刊>Journal of the American College of Surgeons >Hepatic resection with reconstruction of the inferior vena cava or hepatic venous confluence for metastatic liver tumor from colorectal cancer.
【24h】

Hepatic resection with reconstruction of the inferior vena cava or hepatic venous confluence for metastatic liver tumor from colorectal cancer.

机译:肝切除合并下腔静脉或肝静脉汇合,用于结直肠癌转移性肝肿瘤。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Resection of colorectal liver metastases infiltrating the inferior vena cava (IVC) or hepatic venous confluence (HVC) is technically feasible, but the procedure frequently involves invasive techniques, and its long-term outcome has not yet been fully described. STUDY DESIGN: From October 1994 through June 2001, 87 patients underwent first curative hepatic resections for colorectal metastases. Nine patients (the IVC/HVC group) received hepatectomy combined with IVC or HVC reconstruction. Clinicopathologic characteristics, surgical results, and patient survival were investigated and compared with those of the remaining 78 patients (the comparison group). RESULTS: Three IVCs and eight hepatic veins were successfully resected and reconstructed by primary closure (n = 3), direct anastomosis (n = 1), or by the use of autologous vein grafts (n = 7). A comparison between the two groups revealed that the primary colorectal tumor stage was similar, but the IVC/HVC group had more (median 4 versus 2, p< 0.05) and larger (median 5.0 versus 3.2 cm, p < 0.05) lesions. The IVC/HVC group required longer operating times (median 600 versus 320 minutes, p < 0.001) and suffered greater blood loss (median 1,034 versus 434 g, p < 0.01) and more extensive liver parenchyma resection (median 585 versus 155 g, p < 0.001). Patients in the IVC/HVC group had a shorter survival time (median survival time 25.8 versus 44.0 months, p < 0.01). CONCLUSIONS: Hepatic resection combined with the IVC or HVC reconstruction for colorectal liver metastases can be performed with acceptable morbidity, and possibly with no mortality. Although no definite conclusion on long-term survival can be drawn from our study, given the limited number of patients, their overall survival was unsatisfactory. Further studies are needed to clarify the contribution of combined resection and reconstruction of IVC/HVC to long-term survival, because surgical resection currently provides the only hope of cure.
机译:背景:切除下腔静脉(IVC)或肝静脉汇合(HVC)的结直肠肝转移瘤在技术上是可行的,但该手术通常涉及侵入性技术,其长期结果尚未得到充分描述。研究设计:从1994年10月到2001年6月,有87例因大肠转移而进行了首次根治性肝切除术。 9名患者(IVC / HVC组)接受了肝切除联合IVC或HVC重建。临床病理特征,手术结果和患者生存率进行了调查,并与其余78例患者(比较组)进行了比较。结果:通过初次闭合(n = 3),直接吻合(n = 1)或使用自体静脉移植(n = 7)成功切除并重建了3个IVC和8条肝静脉。两组之间的比较显示,原发性结肠直肠癌的分期相似,但IVC / HVC组有更多的病变(中位4对2,p <0.05)和更大的病变(中位5.0对3.2 cm,p <0.05)。 IVC / HVC组需要更长的手术时间(中位600分钟vs 320分钟,p <0.001),失血量更大(中位1,034 vs 434 g,p <0.01)和更广泛的肝实质切除术(中位585 vs 155 g,p) <0.001)。 IVC / HVC组的患者生存时间较短(中位生存时间25.8对44.0个月,p <0.01)。结论:肝切除结合IVC或HVC重建治疗大肠肝转移的发病率可以接受,并且可能没有死亡率。尽管从我们的研究中无法得出长期生存的确切结论,但鉴于患者数量有限,他们的总体生存情况并不理想。有必要进行进一步的研究以阐明IVC / HVC联合切除和重建对长期生存的贡献,因为手术切除目前提供了治愈的唯一希望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号